Company Filing History:
Years Active: 2017
Title: Annalucia Serafino: Innovator in Pharmaceutical Applications
Introduction
Annalucia Serafino is a notable inventor based in Abano Terme, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer. Her work focuses on the therapeutic use of bioconjugates that enhance the efficacy of antitumoral drugs.
Latest Patents
Annalucia holds a patent for the "Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias." This invention describes a novel application in oncology, utilizing bioconjugates formed by the conjugation of hyaluronic acid (HA) with chemotherapeutic agents such as Irinotecan, Doxorubicin, Paclitaxel, Cis-platinum, and 5-Fluorouracyl (5-FU). The patent highlights the biological behavior, action mechanisms, efficacy, and tolerability of these pharmaceutical preparations, particularly focusing on formulations based on ONCOFID-S and ONCOFID-D, which promote the differentiation of tumoral cells towards a non-transformed phenotype.
Career Highlights
Annalucia is associated with Fidia Farmaceutici S.p.a., where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key figure in the pharmaceutical industry, particularly in the area of cancer treatment.
Collaborations
Annalucia collaborates with esteemed colleagues, including Monica Campisi and Davide Renier, who contribute to her research initiatives and enhance the impact of her work.
Conclusion
Annalucia Serafino's contributions to pharmaceutical innovations, particularly in cancer treatment, underscore her role as a leading inventor in her field. Her patented work demonstrates the potential of bioconjugates in improving therapeutic outcomes for patients.